Shih Evelyn K, Beslow Lauren A, Natarajan Shobha S, Falkensammer Christine B, Messé Steven R, Ichord Rebecca N
From the Divisions of Neurology (E.K.S., L.A.B., R.N.I.) and Cardiology (S.S.N., C.B.F.), Children's Hospital of Philadelphia, PA; and Departments of Neurology (E.K.S., L.A.B., S.R.M., R.N.I.) and Pediatrics (E.K.S., L.A.B., S.S.N., C.B.F., R.N.I.), University of Pennsylvania, Philadelphia.
Neurology. 2021 Nov 23;97(21):e2096-e2102. doi: 10.1212/WNL.0000000000012892. Epub 2021 Oct 14.
To determine the significance of patent foramen ovale (PFO) in childhood stroke, we compared PFO prevalence, PFO features, and stroke recurrence risk in 25 children with cryptogenic arterial ischemic stroke (AIS), 54 children with AIS from a known etiology, and 209 healthy controls.
We performed a case-control analysis of a 14-year prospectively enrolled single-center cohort of children with AIS who underwent transthoracic echocardiogram (TTE) and compared them to TTEs of otherwise healthy children evaluated for benign cardiac concerns. Stroke patients 29 days to 18 years of age at stroke ictus with confirmed acute AIS on imaging, availability of complete diagnostic studies of stroke risk factors, including TTE images available for central review, and at least 1 follow-up evaluation after index stroke were included. Presence of PFO and high-risk PFO features were assessed by 2 independent, blinded reviewers and compared between groups with the Fisher exact test. Stroke/TIA recurrence risk was determined from Cox proportional hazards models.
Of 154 children with first-ever AIS, 79 were eligible; 25 had cryptogenic AIS, and 54 had a known cause. PFO prevalence was higher in the cryptogenic group (7, 28%) compared to both the known stroke etiology group (3, 5.6%, = 0.009) and controls without stroke (24, 11.5%, = 0.03). There were no significant differences in presence of right-to-left shunt and atrial septal aneurysm. Median follow-up time for entire stroke cohort was 20.9 months. Stroke-free recurrence at 2-years did not differ between children with and without PFO (HR 2.0, 95% CI 0.4-9.3, = 0.39).
PFO prevalence was higher in children with cryptogenic stroke compared to patients with AIS with known etiology and healthy controls. PFO was not associated with increased recurrence risk. Optimal secondary preventive treatment in children with cryptogenic stroke and PFO remains uncertain and requires further study.
This study provides Class III evidence that children with cryptogenic ischemic stroke have an increased frequency of PFO compared to children with ischemic stroke of known etiology and healthy controls.
为了确定卵圆孔未闭(PFO)在儿童卒中中的意义,我们比较了25例隐源性动脉缺血性卒中(AIS)患儿、54例已知病因的AIS患儿和209例健康对照者的PFO患病率、PFO特征及卒中复发风险。
我们对一个前瞻性纳入的单中心队列中14年间接受经胸超声心动图(TTE)检查的AIS患儿进行病例对照分析,并将他们与因良性心脏问题接受评估的健康儿童的TTE结果进行比较。纳入卒中发作时年龄在29天至18岁、影像学确诊为急性AIS、可获得卒中危险因素的完整诊断研究(包括可供中心审查的TTE图像)且首次卒中后至少有1次随访评估的患儿。由2名独立的、不知情的审阅者评估PFO的存在及高危PFO特征,并采用Fisher精确检验在组间进行比较。卒中/短暂性脑缺血发作(TIA)复发风险由Cox比例风险模型确定。
在154例首次发生AIS的患儿中,79例符合条件;25例为隐源性AIS,54例有已知病因。与已知卒中病因组(3例,5.6%,P = 0.009)和无卒中的对照组(24例,11.5%,P = 0.03)相比,隐源性组的PFO患病率更高。右向左分流和房间隔瘤的存在无显著差异。整个卒中队列的中位随访时间为20.9个月。有PFO和无PFO的患儿2年无卒中复发情况无差异(风险比2.0,95%置信区间0.4 - 9.3,P = 0.39)。
与已知病因的AIS患儿和健康对照相比,隐源性卒中患儿的PFO患病率更高。PFO与复发风险增加无关。隐源性卒中和PFO患儿的最佳二级预防治疗仍不确定,需要进一步研究。
本研究提供III级证据,表明与已知病因的缺血性卒中患儿和健康对照相比,隐源性缺血性卒中患儿的PFO发生率更高。